Società Wound Management Technologies Inc Other OTC
Azioni
US98211X1063
Prodotti farmaceutici
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Soft Tissue Repair Products
84,4
%
| - | - | 55 | 84,4 % | - |
Bone Fusion Products
15,3
%
| - | - | 10 | 15,3 % | - |
Royalty
0,3
%
| 0 | 0,4 % | 0 | 0,3 % | -.--% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 46 | 100,0 % | 65 | 100,0 % | +41,77% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 11/04/18 |
Chief Tech/Sci/R&D Officer | - | 01/01/23 | |
Chief Tech/Sci/R&D Officer | 39 | 01/07/21 | |
Susan Dieter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bill Fitzgerald
CMP | Compliance Officer | - | - |
Callon Nichols
IRC | Investor Relations Contact | - | 01/08/19 |
Seth Yon
PRN | Corporate Officer/Principal | - | 01/01/18 |
Tricia Matteson
SAM | Sales & Marketing | - | - |
Carla Day
SAM | Sales & Marketing | - | - |
W. David Lee
PRN | Corporate Officer/Principal | - | 01/01/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 01/01/22 |
Roszell Mack
BRD | Director/Board Member | 57 | 01/01/22 |
Eric Major
BRD | Director/Board Member | 55 | 01/06/23 |
James Stuckert
BRD | Director/Board Member | 86 | 21/09/15 |
Robert Desutter
BRD | Director/Board Member | 55 | 12/10/20 |
Ron Nixon
CEO | Chief Executive Officer | 68 | 15/03/19 |
Sara Ortwein
BRD | Director/Board Member | 65 | 18/12/20 |
Ann Salamone
BRD | Director/Board Member | 73 | 29/08/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 8 625 201 | 3 443 359 ( 39,92 %) | 0 | 39,92 % |
Coordinate società
Settore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
+32,36% | 709 Mrd | |
+30,77% | 595 Mrd | |
-1,60% | 367 Mrd | |
+20,07% | 334 Mrd | |
+6,04% | 289 Mrd | |
+14,77% | 239 Mrd | |
+9,13% | 211 Mrd | |
-3,97% | 203 Mrd | |
+9,27% | 171 Mrd |